I was going to call them and ask about their product but couldn't find a phone number on their website. Only an email address contact for investment information. They list a series of publications related to melanoma and solid tumors.
Plenty of published results on their trials can be found here
It is definitely not DCvax-L despite being lysate based. And one of the 2 flavors does not even extract monocytes to grow DCs, it injects the lysate into the patient so it is recognized by DCs and other APC in vivo.
There core differentiator from the other numerous ATL-DCs is that they embed the lysate into a particle made of yeast cell wall material. Supposedly makes it tastier to the DCs.
They do extract the lysate via a freeze-thaw cycle, which I think was NWBO's core differentiator from the late 1990s.